Prognostic significance of KIF2C and its association with lactate metabolism in hepatocellular carcinoma
Background Hepatocellular carcinoma (HCC) remains a global health challenge with limited therapeutic options. Recent evidence suggests that protein lactylation, a novel post-translational modification (PTM) driven by lactate, plays a crucial role in tumor remodeling. However, the specific regulators mediating the lactylation landscape in HCC are not fully elucidated. Methods We integrated weighted gene co-expression network analysis (WGCNA) and analysis of differentially expressed genes (DEGs) to identify key lactylation-related genes in HCC. The clinical significance of kinesin family member 2C (KIF2C) was validated using The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases. Functional assays, including Cell Counting Kit-8 (CCK-8), wound-healing, and Transwell assays, were performed to evaluate the effects of KIF2C on HCC cell viability, migration. Lactate measurements and Western blot analyses were conducted to assess changes in lactate levels and metabolism-, apoptosis-, and epithelial–mesenchymal transition (EMT)-related protein expression following KIF2C manipulation. Results KIF2C was identified as a candidate hub gene, with consistent overexpression in HCC across multiple cohorts and validation experiments. High KIF2C expression was associated with poor prognosis. Functional assays in Huh7 cells suggested that KIF2C silencing reduced hexokinase 2 (HK2) expression and lactate abundance, whereas KIF2C overexpression was accompanied by opposite changes. These findings suggest a potential association between KIF2C expression and lactate-related metabolic alterations in HCC cells. Conclusion Elevated KIF2C expression was associated with adverse clinical features and a lactate-related metabolic phenotype in HCC. Functional experiments were observed that KIF2C expression manipulation altered cellular lactate levels and metabolism-related protein expression. However, the underlying molecular mechanisms and potential involvement of protein lactylation remain to be investigated.
Authors
- Wensheng Qiu (ORCID: https://orcid.org/0000-0002-5063-7830)
- Guangtan Du (ORCID: https://orcid.org/0009-0004-7045-7273)
- Haowen Liu (ORCID: https://orcid.org/0009-0004-7384-7963)
- Jiashuo Li
- Qianqian Liu
- Shasha Wang (ORCID: https://orcid.org/0009-0006-3979-6095)
- Liwei Shen
- Lihua Zhang
- Boyu Qiu
Institutions
- Qingdao University (CN)
- Peking University (CN)
- Affiliated Hospital of Qingdao University (CN)
- Peking University People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-11-03
- DOI
- https://doi.org/10.3389/fimmu.2026.1982838
- Primary Topic
- Cancer, Hypoxia, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00